BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18766969)

  • 21. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.
    Peyrl A; Sauermann R; Traunmueller F; Azizi AA; Gruber-Olipitz M; Gupper A; Slavc I
    Clin Pharmacokinet; 2009; 48(4):265-71. PubMed ID: 19492871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma.
    Spina M; Chimienti E; Martellotta F; Vaccher E; Berretta M; Zanet E; Lleshi A; Canzonieri V; Bulian P; Tirelli U
    Cancer; 2010 Mar; 116(6):1495-501. PubMed ID: 20108270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
    Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
    Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal chemotherapy with antineoplastic agents in children.
    Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
    Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A; Rudnicka H; Murawska M
    Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
    Gaviani P; Corsini E; Salmaggi A; Lamperti E; Botturi A; Erbetta A; Milanesi I; Legnani F; Pollo B; Silvani A
    Neurol Sci; 2013 Dec; 34(12):2151-7. PubMed ID: 23525755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers.
    Jurczak W; Kroll-Balcerzak R; Giebel S; Machaczka M; Giza A; Ogórka T; Fornagiel S; Rybka J; Wróbel T; Kumiega B; Skotnicki AB; Komarnicki M
    Med Oncol; 2015 Apr; 32(4):90. PubMed ID: 25716885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal liposomal cytarabine in relapsed or refractory infant and pediatric leukemias: the Children's Hospital of Philadelphia experience and review of the literature.
    Seif AE; Reilly AF; Rheingold SR
    J Pediatr Hematol Oncol; 2010 Nov; 32(8):e349-52. PubMed ID: 20962675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
    Jaeckle KA; Phuphanich S; Bent MJ; Aiken R; Batchelor T; Campbell T; Fulton D; Gilbert M; Heros D; Rogers L; O'Day SJ; Akerley W; Allen J; Baidas S; Gertler SZ; Greenberg HS; LaFollette S; Lesser G; Mason W; Recht L; Wong E; Chamberlain MC; Cohn A; Glantz MJ; Gutheil JC; Maria B; Moots P; New P; Russell C; Shapiro W; Swinnen L; Howell SB
    Br J Cancer; 2001 Jan; 84(2):157-63. PubMed ID: 11161370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma.
    Garcia-Marco JA; Panizo C; Garcia ES; Deben G; Alvarez-Larran A; Barca EG; Sancho JM; Penarrubia MJ; Garcia-Cerecedo T; Garcia Vela JA
    Cancer; 2009 May; 115(9):1892-8. PubMed ID: 19235254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas].
    Kumiega B; Jurczak W; Fornagiel S; Dzietczenia J; Skotnicki AB
    Przegl Lek; 2013; 70(4):187-90. PubMed ID: 23991555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.
    Bleyer WA
    Clin Cancer Res; 1999 Nov; 5(11):3349-51. PubMed ID: 10589743
    [No Abstract]   [Full Text] [Related]  

  • 33. Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.
    Gaviani P; Silvani A; Corsini E; Erbetta A; Salmaggi A
    Neurol Sci; 2009 Jun; 30(3):251-4. PubMed ID: 19259616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
    Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
    J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.
    Kripp M; Hofheinz RD
    Int J Nanomedicine; 2008; 3(4):397-401. PubMed ID: 19337408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Liposomal cytarabine for the treatment of leptomeningeal dissemination of central nervous system tumours in children and adolescents].
    Moreno L; García Ariza MA; Cruz O; Calvo C; Fuster JL; Salinas JA; Moscardo C; Portugal R; Merino JM; Madero L
    An Pediatr (Barc); 2016 Nov; 85(5):274.e1-274.e8. PubMed ID: 27086069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal liposomal cytarabine: more friend than foe?
    Bhojwani D; Pui CH
    Leuk Lymphoma; 2008 Aug; 49(8):1427-30. PubMed ID: 18766957
    [No Abstract]   [Full Text] [Related]  

  • 39. Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.
    Sancho JM; Deben G; Parker A; Piñana JL; Bolam S; Sánchez-García E; Giménez E; Pascual T; Fernández-Abellán P; Palomera L; Ribera JM
    Int J Hematol; 2007 Jul; 86(1):33-6. PubMed ID: 17675264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
    Berg SL; Balis FM; Zimm S; Murphy RF; Holcenberg J; Sato J; Reaman G; Steinherz P; Gillespie A; Doherty K
    J Clin Oncol; 1992 Jan; 10(1):143-8. PubMed ID: 1727916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.